Zippora Siregar (L) and Stefy Yully Nataly, partners at William Hendrik & Siregar Djojonegoro, are involved in various healthcare transactions in Indonesia and promoting the country as a medical tourism destination. Their expertise includes understanding healthcare standards, financing, and staying updated on legal issues.
Can you provide specific examples of recent healthcare-related cases or transactions your firm has handled in Indonesia? What were the key challenges and how did your team overcome them?
Within the last few years, we have handled numerous. We assist and advice in healthcare transactions, particularly on mergers and acquisitions, financing and cooperation between the Indonesian and International healthcare providers. We are also the key player in the preparation and development of the Specific Economic Zone Project in healthcare sector (the “SEZ Project of Healthcare”). The SEZ Project of Healthcare marks the development of healthcare in Indonesia through its aim promoting Indonesia as a medical tourism destination by attracting foreign patients to seek healthcare in Indonesia. As one of the Indonesian Government’s top goals, this project not only collaborates with prestigious international healthcare providers but also offers an attractive tax incentive package for investors under the Specific Economic Zone (SEZ) framework.
One of the key challenges is finding legal certainty in the Indonesian healthcare law and its implementing regulations. Hence, this poses a challenge to provide a strong position of legal advice for our client. Nonetheless, the Indonesian Government’s recent enactment of Law Number 17 of 2023 (‘New Health Law’) and the issuance of Government Regulation Number 28 of 2024 (‘GR 28 of 2024’) as its implementing regulation demonstrate a significant commitment to advancing the healthcare sector. However, since it is something new, these legislatives still need to be tested in practice. These legislative should provide clear guidelines and reinforce legal certainty, creating a stable and promising environment for investment and innovation. In addition, an adjustment and amendment of detail implementing regulations in the ministry level or organization body also need to be made in order to be in line with the spirit of New Health Law and GR 28 of 2024.
To circumvent any challenges in relation to the implementation of the new laws, our team undergoes continuous training and maintain open lines of communication with the relevant regulatory authorities to ensure that our advice is aligned with the latest laws of Indonesian healthcare.
What unique expertise or resources does your firm offer that sets you apart from other law firms when it comes to handling healthcare matters in Indonesia?
One of our firm’s specialization is in the healthcare sector in Indonesia. The firm specializes through our unique blend of expertise and resources. We have a deep understanding of both the local regulatory framework and the complex regulatory of national and international healthcare standards. Our team includes professionals with extensive experience in the financing, project development and acquisition of companies within the healthcare sector. We are also active within the healthcare sector and actively communicate with the key players to get some insights on any update of the legal issues.
